What about long-term use
Diabetes Metab Syndr (2017) 11(3):22530.10.1016/j.dsx.2016.09.003 40 BurcelinRGourdyP
The Cold vs
Klicek et al., 2013), bladder (Sucic et al., 2019), and vagina (Jandric et al., 2013), whereas the fistula studies show an additional combining healing effect, providing different combinations of the lesions that were simultaneously included (Figures 3, 4), thereby a proof of the concept for a quite general healing effect (Klicek et al., 2008

Back to Journals International Journal of Nephrology and Renovascular Disease Volume 19 Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease Authors Rajan K, Jutley AK, Holliday MW Jr, Navaneethan SD Received 20 October 2025 Accepted for publication 6 March 2026 Published 23 March 2026 Volume 2026:19 522424 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Pravin Singhal Kavya Rajan, 1 Arjun Krishen Jutley, 2 Michael W Holliday Jr, 3, 4 Sankar D Navaneethan 3 5 1 Innovation Academy High School, Alpharetta, GA, USA
However, the timeline varies based on individual factors including your baseline gut microbiome composition, dietary habits, and how quickly your dose increases